HBsAb
Showing 1 - 25 of 125
Australian Hepatitis and Risk Survey in Prisons
Recruiting
- Hepatitis C
- +2 more
- Point-of-care hepatitis C antibody test
- +5 more
-
Hume, Australian Capital Territory, Australia
- +23 more
Apr 20, 2023
Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing
Recruiting
- Vaccination Reaction
- +4 more
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Sep 7, 2023
Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)
Not yet recruiting
- Chronic Hepatitis b
- +2 more
- Anti-PD-1 antibody
- +2 more
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)
Not yet recruiting
- Chronic Hepatitis b
- ISA104
- Placebo
-
Rotterdam, NetherlandsErasmus MC
Apr 21, 2023
Hepatitis B Vaccine Boosters Among Neonatally Vaccinated
Recruiting
- Hepatitis B Vaccine Adverse Reaction
- hepatitis B vaccine(HepB)
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Mar 7, 2022
Malaria Trial (R21/Matrix-M™)
Recruiting
- Malaria
- R21/Matrix-M™
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
Jan 13, 2023
Chronic Hepatitis B Trial (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Herston, Queensland, Australia
- +7 more
Jan 23, 2023
Single-cell RNA Sequencing Resolves Regulatory Role of HBV on
Recruiting
- HBV
- Primary Liver Cancer
- HBV DNA Sequencing
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 22, 2022
Access HBV Assays - European Union Clinical Trial Protocol -
Recruiting
- HBV
- Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays
-
Amiens, France
- +4 more
Jun 23, 2022
Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Victoria, British Columbia, Canada
- +10 more
Jan 23, 2023
Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)
Recruiting
- Chronic Hepatitis B
- continuous treatment
- pulse therapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 13, 2022
Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis
Recruiting
- Chronic Hepatitis b
- test of HBV DNA
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an JiaotongUniversity
Mar 28, 2022
HIV Infection, Hepatitis B Trial in Worldwide (HEPLISAV-B, ENGERIX-B)
Recruiting
- HIV Infection
- Hepatitis B
- HEPLISAV-B
- ENGERIX-B
-
Birmingham, Alabama
- +47 more
Dec 13, 2022
Chronic Hepatitis b Trial in Hong Kong (RBD1016, Placebo, Entecavir)
Recruiting
- Chronic Hepatitis b
- RBD1016
- +2 more
-
Hong Kong, ChinaThe University of Hong Kong
Apr 24, 2022
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Hepatitis B, Chronic Trial in Worldwide (administration of SLGN in arm C, Discontinuation of NUC treatment in arms B and C)
Recruiting
- Hepatitis B, Chronic
- administration of SLGN in arm C
- Discontinuation of NUC treatment in arms B and C
-
Lyon, France
- +7 more
Mar 11, 2022
Kidney Transplantation, HBV Trial in Chengdu (prophylaxis regimen)
Recruiting
- Kidney Transplantation
- HBV
- prophylaxis regimen
-
Chengdu, Sichuan, ChinaTao Lin
Jul 21, 2021
Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)
Enrolling by invitation
- Hepatitis B Reactivation
- +3 more
-
Seoul, Korea, Republic ofJeong Won Jang
Dec 16, 2022
NMO Spectrum Disorder Trial in Guangzhou (HBM9161 Injection)
Completed
- NMO Spectrum Disorder
- HBM9161 Injection
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Jan 9, 2022
Hepatitis A, Hepatitis B Trial in Changsha (Inactivated Hepatitis A vaccine (HAV), Combined hepatitis A and hepatitis B vaccine
Completed
- Hepatitis A
- Hepatitis B
- Inactivated Hepatitis A vaccine (HAV)
- Combined hepatitis A and hepatitis B vaccine (HABV)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jul 26, 2021
Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease Trial in Baltimore (Heplisav-B Injectable Product, 2-dose regimen,
Recruiting
- Hepatitis B
- +2 more
- Heplisav-B Injectable Product, 2-dose regimen
- Heplisav-B Injectable Product, 3-dose regimen
-
Baltimore, MarylandMercy Medical Center
Aug 24, 2022
Hepatitis B Trial in Yangon (Tenofovir Disoproxil Fumarate 300 mg daily; HBV birth dose vaccine; hepatitis B immune globulin
Recruiting
- Hepatitis B
- Tenofovir Disoproxil Fumarate 300 mg daily; HBV birth dose vaccine; hepatitis B immune globulin (HBIG)
- Regular Myanmar treatment
-
Yangon, MyanmarBK Kee Clinic
Aug 3, 2021
Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection
Recruiting
- Malaria,Falciparum
- R21/Matrix-M
- +2 more
-
Kilifi, KenyaKEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Sep 14, 2022